Unknown

Dataset Information

0

Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.


ABSTRACT: Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14+ monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloid-derived suppressor cells when normal monocytes are exposed to glioma conditioned media.

SUBMITTER: Kumar R 

PROVIDER: S-EPMC5493295 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.

Kumar Ravi R   de Mooij Tristan T   Peterson Timothy E TE   Kaptzan Tatiana T   Johnson Aaron J AJ   Daniels David J DJ   Parney Ian F IF  

PloS one 20170630 6


Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor  ...[more]

Similar Datasets

| S-EPMC5249124 | biostudies-literature
| 2381881 | ecrin-mdr-crc
| S-EPMC5728145 | biostudies-literature
| S-EPMC3958743 | biostudies-literature
| S-EPMC2940603 | biostudies-literature
| S-EPMC4811451 | biostudies-literature
| S-EPMC5540616 | biostudies-literature
| S-EPMC4038578 | biostudies-literature
| S-EPMC3784535 | biostudies-literature
| S-EPMC8027615 | biostudies-literature